INDIAN JOURNAL OF CANCER, cilt.57, sa.1, ss.55-61, 2020 (SCI-Expanded)
Background and Aim: Our retrospective, single-center study aimed at evaluating the efficacy and safety of eribulin in heavily pretreated metastatic breast cancer (MBC) in routine clinical practice.